The ovarian endothelin network: an evolving story

Trends in Endocrinology and Metabolism

Volumn 18, Issue 10, 2007, Pages 379-385

  Meidan, Rina ^a   Levy, Nitzan ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR;

CORPUS LUTEUM; GRANULOSA CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUTEOLYSIS; OVARY; OVARY CARCINOMA; OVULATION; PRIORITY JOURNAL; REPRODUCTION; REVIEW; STEROIDOGENESIS;

ASPARTIC ENDOPEPTIDASES; CORPUS LUTEUM; ENDOTHELIN-1; ENDOTHELIN-2; ENDOTHELINS; FEMALE; HUMANS; METALLOENDOPEPTIDASES; OVARIAN NEOPLASMS; OVARY; RECEPTORS, ENDOTHELIN; RNA, MESSENGER;

EID: 36249026290     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2007.09.002     Document Type: Review

References (79)

1. Grant K., et al. Endothelin-1: a multifunctional molecule in cancer. Br. J. Cancer 88 (2003) 163-166
2. Kedzierski R.M., and Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 851-876
3. Yanagisawa H., et al. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125 (1998) 825-836
4. Meidan R., and Levy N. Endothelin-1 receptors and biosynthesis in the corpus luteum: molecular and physiological implications. Domest. Anim. Endocrinol. 23 (2002) 287-298
5. Hirai Y., et al. Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study. J. Hypertens. 22 (2004) 713-718
6. Callera G., et al. Vasoactive peptides in cardiovascular (patho)physiology. Expert Rev. Cardiovasc. Ther. 5 (2007) 531-552
7. Nelson J., et al. The endothelin axis: emerging role in cancer. Nat. Rev. Cancer 3 (2003) 110-116
8. Arinami T., et al. Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. Am. J. Hum. Genet. 48 (1991) 990-996
9. Inoue A., et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl Acad. Sci. USA. 86 (1989) 2863-2867
10. Masaki T. Historical review: endothelin. Trends Pharmacol. Sci. 25 (2004) 219-224
11. Saida K., et al. Sequence analysis and expression of the mouse full-length vasoactive intestinal contractor/endothelin-2 gene (EDN2): comparison with the endothelin-1 gene (EDN1). Clin. Sci. (Lond.) 103 Suppl 48 (2002) 84S-89S
12. Grimshaw M.J., et al. A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res. 64 (2004) 2461-2468
13. Rubanyi G.M., and Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46 (1994) 325-415
14. Dupin E., et al. The neural crest stem cells: control of neural crest cell fate and plasticity by endothelin-3. An. Acad. Bras. Cienc. 73 (2001) 533-545
15. Arai H., et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348 (1990) 730-732
16. Sakurai T., et al. Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348 (1990) 732-735
17. Schneider M.P., et al. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 731-759
18. Bremnes T., et al. Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 275 (2000) 17596-17604
19. Paasche J.D., et al. Mechanisms of endothelin receptor subtype-specific targeting to distinct intracellular trafficking pathways. J. Biol. Chem. 276 (2001) 34041-34050
20. Foster N., et al. Lysosomal traffic of liganded endothelin B receptor. Biochim. Biophys. Acta 1642 (2003) 45-52
21. Sawamura T., et al. Characterization of phosphoramidon-sensitive metalloproteinases with endothelin-converting enzyme activity in porcine lung membrane. Biochim. Biophys. Acta 1161 (1993) 295-302
22. Xu D., et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78 (1994) 473-485
23. Yanagisawa H., et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J. Clin. Invest. 105 (2000) 1373-1382
24. Korth P., et al. Cellular distribution of endothelin-converting enzyme-1 in human tissues. J. Histochem. Cytochem. 47 (1999) 447-462
25. Schmidt M., et al. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 356 (1994) 238-243
26. Meidan R., et al. Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain. J. Biol. Chem. 280 (2005) 40867-40874
27. Emoto N., et al. Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail. J. Biol. Chem. 274 (1999) 1509-1518
28. Valdenaire O., et al. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur. J. Biochem. 264 (1999) 341-349
29. Muller L., et al. Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J. Biol. Chem. 278 (2003) 545-555
30. Klipper E., et al. Identification of a novel alternatively spliced variant endothelin converting enzyme-1 lacking a transmembrane domain. Exp. Biol. Med. (Maywood) 231 (2006) 723-728
31. Iwai M., et al. Endothelins inhibit luteinization of cultured porcine granulosa cells. Endocrinology 129 (1991) 1909-1914
32. Kamada S., et al. High levels of immunoreactive endothelin-1 in human follicular fluids. Hum. Reprod. 8 (1993) 674-677
33. Kamada S., et al. Endothelin-1 is an autocrine/paracrine regulator of porcine granulosa cells. J. Endocrinol. Invest. 16 (1993) 425-431
34. Magini A., et al. Expression of endothelin-1 gene and protein in human granulosa cells. J. Clin. Endocrinol. Metab. 81 (1996) 1428-1433
35. Flores J.A. Gene expression of endothelin-1 in the porcine ovary: follicular development. Biol. Reprod. 63 (2000) 1377-1382
36. Shimizu T., et al. Changes in the messenger RNA expressions of the endothelin-1 and angiotensin systems in mature follicles of the superovulated bovine ovary. J. Reprod. Dev. 53 (2007) 655-662
37. Tedeschi C., et al. Rat ovarian granulosa cell as a site of endothelin reception and action: attenuation of gonadotropin-stimulated steroidogenesis via perturbation of the A-kinase signaling pathway. Biol. Reprod. 51 (1994) 1058-1065
38. Plonowski A., et al. Correlation between 21 amino acid endothelin, intrafollicular steroids and follicle size in stimulated cycles. Hum. Reprod. 14 (1999) 2323-2327
39. O'Shea J.D., et al. Cellular composition of the cyclic corpus luteum of the cow. J. Reprod. Fertil. 85 (1989) 483-487
40. Redmer D.A., et al. Angiogenic activity of bovine corpora lutea at several stages of luteal development. J. Reprod. Fertil. 82 (1988) 627-634
41. Hinckley S.T., and Milvae R.A. Endothelin-1 mediates prostaglandin F(2alpha)-induced luteal regression in the ewe. Biol. Reprod. 64 (2001) 1619-1623
42. Meidan R., et al. Intraovarian regulation of luteolysis. J. Reprod. Fertil. Suppl. 54 (1999) 217-228
43. Girsh E., et al. Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2 alpha. Endocrinology 137 (1996) 5191-5196
44. Levy N., et al. Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis. Endocrinology 142 (2001) 5254-5260
45. Ohtani M., et al. Real-time relationships between intraluteal and plasma concentrations of endothelin, oxytocin, and progesterone during prostaglandin F2alpha-induced luteolysis in the cow. Biol. Reprod. 58 (1998) 103-108
46. Levy N., et al. Administration of prostaglandin f(2 alpha) during the early bovine luteal phase does not alter the expression of ET-1 and of its type A receptor: a possible cause for corpus luteum refractoriness. Biol. Reprod. 63 (2000) 377-382
47. Shirasuna K., et al. A cooperative action of endothelin-1 with prostaglandin F(2alpha) on luteal function in the cow. Domest. Anim. Endocrinol. 31 (2006) 186-196
48. Milvae R.A. Inter-relationships between endothelin and prostaglandin F2alpha in corpus luteum function. Rev. Reprod. 5 (2000) 1-5
49. Shirasuna K., et al. Real-time relationships in intraluteal release among prostaglandin F2alpha, endothelin-1, and angiotensin II during spontaneous luteolysis in the cow. Biol. Reprod. 71 (2004) 1706-1711
50. Boiti C., et al. Vasoactive peptides in the luteolytic process activated by PGF2alpha in pseudopregnant rabbits at different luteal stages. Biol. Reprod. 77 (2007) 156-164
51. Wright M.F., et al. Prostaglandin F(2alpha) regulation of the bovine corpus luteum endothelin system during the early and midluteal phase. Biol. Reprod. 65 (2001) 1710-1717
52. Girsh E., et al. Effect of endothelin-1 on bovine luteal cell function: role in prostaglandin F2alpha-induced antisteroidogenic action. Endocrinology 137 (1996) 1306-1312
53. Apa R., et al. Endothelin-1: expression and role in human corpus luteum. Am. J. Reprod. Immunol. 40 (1998) 370-376
54. Girsh E., and Dekel N. Involvement of endothelin-1 and its receptors in PGF2alpha-induced luteolysis in the rat. Mol. Reprod. Dev. 63 (2002) 71-78
55. Watanabe S., et al. Effect of intraluteal injection of endothelin type A receptor antagonist on PGF2alpha-induced luteolysis in the cow. J. Reprod. Dev. 52 (2006) 551-559
56. Ko C., et al. Endothelin-2 in ovarian follicle rupture. Endocrinology 147 (2006) 1770-1779
57. Palanisamy G.S., et al. A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice. Mol. Endocrinol. 20 (2006) 2784-2795
58. Levy N., et al. Hormonal regulation and cell-specific expression of endothelin-converting enzyme 1 isoforms in bovine ovarian endothelial and steroidogenic cells. Biol. Reprod. 68 (2003) 1361-1368
59. Berisha B., et al. The expression of angiotensin and endothelin system members in bovine corpus luteum during estrous cycle and pregnancy. Endocrine 19 (2002) 305-312
60. Yoshioka S., et al. Endothelin-converting enzyme-1 is expressed on human ovarian follicles and corpora lutea of menstrual cycle and early pregnancy. J. Clin. Endocrinol. Metab. 83 (1998) 3943-3950
61. Choudhary E., et al. Prostaglandin F2alpha (PGF2alpha) independent and dependent regulation of the bovine luteal endothelin system. Domest. Anim. Endocrinol. 27 (2004) 63-79
62. Mamluk R., et al. Characterization and regulation of type A endothelin receptor gene expression in bovine luteal cell types. Endocrinology 140 (1999) 2110-2116
63. Gentili M., et al. Distinct expression of endothelin receptor subtypes A and B in luteinized human granulosa cells. Horm. Metab. Res. 33 (2001) 573-576
64. Flores J.A., et al. Nature of endothelin binding in the porcine ovary. Endocrinology 136 (1995) 5014-5019
65. Mancina R., et al. Identification, characterization, and biological activity of endothelin receptors in human ovary. J. Clin. Endocrinol. Metab. 82 (1997) 4122-4129
66. Hirata Y., and Emori T. Cellular mechanism of endothelin-induced nitric oxide synthesis by cultured bovine endothelial cells. J. Cardiovasc. Pharmacol. 22 Suppl 8 (1993) S225-S228
67. Bagnato A., et al. Emerging role of the endothelin axis in ovarian tumor progression. Endocr. Relat. Cancer 12 (2005) 761-772
68. Salani D., et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol. 157 (2000) 1703-1711
69. Del Bufalo D., et al. Endothelin-1 protects ovarian carcinoma cells against paclitaxel-induced apoptosis: requirement for Akt activation. Mol. Pharmacol. 61 (2002) 524-532
70. Auersperg N., et al. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22 (2001) 255-288
71. Penna C., et al. Effect of endothelins on the cardiovascular system. J. Cardiovasc. Med. (Hagerstown) 7 (2006) 645-652
72. Clerk A., and Sugden P.H. Regulation of phospholipases C and D in rat ventricular myocytes: stimulation by endothelin-1, bradykinin and phenylephrine. J. Mol. Cell. Cardiol. 29 (1997) 1593-1604
73. Kawanabe Y., and Nauli S.M. Involvement of extracellular Ca2+ influx through voltage-independent Ca2+ channels in endothelin-1 function. Cell. Signal. 17 (2005) 911-916
74. Pollock D.M., et al. Endothelin receptors and calcium signaling. FASEB J. 9 (1995) 1196-1204
75. Yamboliev I.A., et al. Endothelin-1 activates MAP kinases and c-Jun in pulmonary artery smooth muscle. Pulm. Pharmacol. Ther. 11 (1998) 205-208
76. Kodama H., et al. Role of EGF receptor and Pyk2 in endothelin-1-induced ERK activation in rat cardiomyocytes. J. Mol. Cell. Cardiol. 34 (2002) 139-150
77. Vacca F., et al. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Res. 60 (2000) 5310-5317
78. Taurin S., et al. Gbetagamma-mediated prostacyclin production and cAMP-dependent protein kinase activation by endothelin-1 promotes vascular smooth muscle cell hypertrophy through inhibition of glycogen synthase kinase-3. J. Biol. Chem. 282 (2007) 19518-19525
79. Klipper E., et al. Characterization of endothelin-1 and nitric oxide generating systems in corpus luteum-derived endothelial cells. Reproduction 128 (2004) 463-473